Aging Baby Boomers

1.94k followers • 11 symbols Watchlist by Yahoo Finance

This basket consists of stocks that benefit from the needs of aging baby boomers.

11 symbols

Zacks
Top Stock Reports for Booking Holdings, Allergan & Honda Motor Co.
Top Stock Reports for Booking Holdings, Allergan & Honda Motor Co.
Zacks
International Flavors-Neptune Team to Co-Develop CBD Products
International Flavors (IFF) focused on developing hemp-derived CBD products for customers in natural health & wellness products.
Zacks
Newell Stock Rises 33% on Robust Transformational Gains
Newell (NWL) progresses well with the Transformation Plan, which is driving its performance and positioning it well for growth.
Financial Times
AbbVie readies $27bn bond sale to finance Allergan takeover
Pharmaceutical company AbbVie prepared to sell one of the largest US corporate bond deals on record on Tuesday, as the company seeks to finance its takeover of former-rival Allergan. AbbVie is looking to borrow in the region of $27bn, according to people familiar with investor conversations. At that size, it will be the same size as Comcast’s $27bn bond sale in October 2018, to become the joint-fourth largest deal ever.
Zacks
The Zacks Analyst Blog Highlights: Novo Nordisk, Allergan, Sanofi, Novartis and J&J
The Zacks Analyst Blog Highlights: Novo Nordisk, Allergan, Sanofi, Novartis and J&J
Zacks
The Zacks Analyst Blog Highlights: Mastercard, UnitedHealth, Merck, Qualcomm and CVS Health
The Zacks Analyst Blog Highlights: Mastercard, UnitedHealth, Merck, Qualcomm and CVS Health
Yahoo Finance
For DaVita subsidiary Vively, it's not just about dialysis care
DaVita renamed its health solutions subsidiary to boost its efforts outside kidney care.
Zacks
Top Analyst Reports for Mastercard, UnitedHealth & Merck
Top Analyst Reports for Mastercard, UnitedHealth & Merck
Zacks
Genesis Healthcare's (GEN) Q3 Earnings Beat, Improve Y/Y
Genesis Healthcare's (GEN) third-quarter results reflect same store occupancy growth, partly offset by lower revenues.
Zacks
Teva (TEVA) Q3 Earnings Miss, Stock Up on Guidance Increase
Teva Pharmaceutical (TEVA) misses earnings estimate but beats the same for sales. The company increases the lower end of its 2019 sales and earnings guidance. Shares rise.
Zacks
Pharma Stock Roundup: AGN, NVO Q3 Earnings, FDA Nod to SNY & NVS' Products
Novo Nordisk (NVO) and Allergan (AGN) release Q3 results. FDA approves Sanofi's quadrivalent flu vaccine for older adults and Novartis' long-acting biosimilar version of Amgen's Neulasta.
Zacks
Aerie (AERI) Q3 Loss Wider, Sales Beat, Guidance Slashed
Aerie (AERI) posts a wider-than-expected Q3 loss and lowers guidance.
Zacks
Norwegian Cruise (NCLH) Q3 Earnings & Revenues Beat Estimates
Norwegian Cruise's (NCLH) top line in third-quarter 2019 gains from strong demand and a record booking trend.
Zacks
Invacare (IVC) Reports Q3 Loss, Misses Revenue Estimates
Invacare (IVC) delivered earnings and revenue surprises of 28.57% and -2.17%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Associated Press
Invacare: 3Q Earnings Snapshot
Zacks
Humana's (HUM) Q3 Earnings Surpass Estimates, Improve Y/Y
Humana's (HUM) third-quarter results reflect higher revenues as well as solid membership growth.
Zacks
Inter Parfums (IPAR) Misses on Q3 Earnings, Raises View
Inter Parfums (IPAR) Q3 performance benefits from growth in European and U.S.-based operations.
Zacks
DaVita (DVA) Earnings and Revenues Beat Estimates in Q3
DaVita (DVA) raises guidance for 2019 following impressive Q3 results.
Zacks
Tenet Healthcare (THC) Q3 Earnings & Revenues Beat Estimates
Tenet Healthcare's (THC) third-quarter earnings gain from its Hospital and Other segment as well as volume growth.
Zacks
Allergan (AGN) Meets Q3 Earnings Estimates, Ups '19 Sales View
Botox, Juveederm fillers, Vraylar drive Allergan's (AGN) third-quarter sales, making up for loss of exclusivity on some brands and lower sales of eye drug, Restasis.
Yahoo Finance
Which Companies Recently Raised Guidance?
Third-quarter EPS season is in the homestretch, with blue-chip Utilities, Financial Services, Consumer and Industrial companies all releasing reports. Through 11/1/2019, Refinitiv reported that 356 S&P 500 companies have now announced 3Q earnings, with 76% coming in above consensus, ahead of the past four-quarters average percentage of 74%. The better-than-expected results have improved the overall forecast for the quarter to a -0.8%, from -3.2% at the start of the reporting season. Our analysts are always on the lookout for companies that raise their outlooks during earnings season. Management’s ability to “raise guidance” can often be a catalyst to strong returns in the quarters ahead. Following are 12 BUY-rated companies in Argus coverage for which management has raised guidance during the current EPS reporting season.
Zacks
International Flavors' (IFF) Q3 Earnings & Sales Lag Estimates
International Flavors (IFF) records growth in operating margin and generates strong free cash flow, aided by productivity savings and acquisition-related synergies in Q3.
Zacks
Allergan (AGN) Q3 Earnings Meet Estimates
Allergan (AGN) delivered earnings and revenue surprises of 0.00% and 4.01%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Associated Press
Allergan: 3Q Earnings Snapshot
Investing.com
Day Ahead: Top 3 Things to Watch
Investing.com - Here's a preview of the top 3 things that could rock markets tomorrow.